|
| |
|
 |
|
|
| [DISPLAY PATENT] |
| |
| |
|
|
| Application no. and date | 13809853.8 (espacenet) (Federated) (European Patent Register), 20130628 | | Patent/reg. no. and date | DK/EP 2867245, 20180912 | | Publication date | 20150506 | | Priority no. and date | US 201261666733 P, 20120629 | | EP pub. no. and date |
EP 2867245 20150506 | | Effective date | | | Applicant/owner | Takeda Pharmaceutical Company Limited, 1-1, Doshomachi 4-chome
Chuo-ku
Osaka-shi
Osaka, JP | | Applicant ref. no. | | | Inventor | NICHOLS, Dave, 300 Shire Way
Lexington, Massachusetts 02421, US | | Representative | | | Opponent | | | IPC Class | A61K 38/17 (2006.01) , C07K 1/00 (2006.01) , C07K 16/00 (2006.01) | | Title | OPRENSNING AF IDURONAT-2-SULFATASE | | Int. application no. | US2013048561 | | Int. publication no. | WO2014005014 | | Related patent (certificate) | | | Status | Ophævet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
|
